EUCTR2021-005996-37-DK进行中（未招募）1 期
Gene and protein expression profiles after treatment of actinic keratosis - PACKS
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Participants should a clinical diagnosis of actinic keratosis
- •2.Participants should be above 18 years old
- •3.Participants must sign an informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1.Known allergic reaction to either 5-flurourocil, imiquimod, or melatonin
- •2.Immunomodulating treatment
- •3.Predictable poor compliance (due to i.e. dementia, substance abuse, psychiatric disease, life-threatening disease or language barriers)
- •4.Pregnant or breastfeeding
- •5.Females not in menopause (defined as no menstruation during the last 12 months) should use a secure birth control (intrauterine devices, hormonal contraceptives including – oral pills, patches, vaginal rings and injections) during the entire period of the trial
研究者
相似试验
已完成
不适用
Molecular networks underlying exercise-induced mitochondrial biogenesis in humansACTRN12621001062819Victoria University40
招募中
不适用
Analysis of therapy-induced changes in gene expression, tumorigenicity and invasiveness of circulating, epithelial tumor cells (CETCs)C18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00015530niversität Bayreuth100
招募中
4 期
HeberproGen StudyDiabetic foot ulcers.RPCEC00000117Center for Genetic Engineering and Biotechnology (CIGB).156
已完成
不适用
Early clinical and biomarker responses after treatment in patients with non-segmental vitiligoVitiligo10035023NL-OMON48618Academisch Medisch Centrum36
已完成
不适用
Analysis of gene expression profiles of peripheral blood cells in obese subjectsObesityJPRN-UMIN000001663Department of Metabolic Medicine, Graduate School of Medicine, Osaka University100